Lyka Labs rose 2.30% to Rs 128.90 at 12:03 IST on BSE ahead of the board meeting today, 28 December 2015, to consider a plan to raise funds by issuing securities.
The announcement was made after market hours on Thursday, 24 December 2015.
Meanwhile, the BSE Sensex was up 139.15 points, or 0.54%, to 25,977.86.
On BSE, so far 96,000 shares were traded in the counter, compared with an average volume of 2.03 lakh shares in the past one quarter.
The stock hit a high of Rs 131.30 and a low of Rs 127.70 so far during the day. The stock hit a 52-week high of Rs 142.90 on 26 November 2015. The stock hit a 52-week low of Rs 24.80 on 26 December 2014.
The stock had underperformed the market over the past one month till 24 December 2015, sliding 9.09% compared with 0.24% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, sliding 67.89% as against Sensex's 0.10% decline.
The small-cap company has an equity capital of Rs 22.04 crore. Face value per share is Rs 10.
On a consolidated basis, net profit of Lyka Labs rose 113.41% to Rs 13.53 crore on 0.53% rise in net sales to Rs 33.95 crore in Q2 September 2015 over Q2 September 2014.
Lyka Labs is a healthcare company. The company manufactures lyophilized products. The primary segment of the company consists of pharmaceutical products/pharma related services.
Powered by Capital Market - Live News
